FindTrial
Sign In

ROLE OF PRESEPSIN IN SEPSIS PATIENTS

PRESEPSIN: A PROGNOSTIC TOOL FOR SEPSIS: A PROSPECTIVE STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099340
Enrollment
76
Registered
2025-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R651- Systemic inflammatory response syndrome (SIRS) of non-infectious origin

Interventions

Intervention1: Serum presepsin level: Blood is drawn through iv cannula on the 1st day of icu admission and tested through ELISA technique Control Intervention1: nil: nil

Sponsors

Dr Kanishka Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS ABOVE 18 YEARS OF AGE

Exclusion criteria

Exclusion criteria: PATIENTS ABOVE 18 YEARS OF AGE, PATIENT NOT ALREADY DIAGNOSED WITH SEPSIS, SEPTIC SHOCK, SIRS

Design outcomes

Primary

MeasureTime frame
To assess the role of presepsin in prognosis of sepsis for better treatment planTimepoint: On day 1 of ICU admission—

Secondary

MeasureTime frame
to assess presepsin as novel biomarker for sepsisTimepoint: after the values of presepsin—

Countries

India

Contacts

Public ContactDr V M Pattanshetti

JAWAHARLAL NEHRU MEDICAL COLLEGE

viceprincipaldrvmp@gmail.com9886175471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026